ELAB
MaterialsPMGC Holdings Inc
$2.13-0.07 (-3.18%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ELAB Today?
No stock-specific AI insight has been generated for ELAB yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$9M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume479K
Avg Volume (10D)—
Shares Outstanding4.5M
ELAB News
24 articles- UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological DisordersYahoo Finance·Apr 28, 2026
- NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in HumansYahoo Finance·Apr 28, 2026
- NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft SystemsYahoo Finance·Apr 23, 2026
- Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)GlobeNewswire Inc.·Apr 21, 2026
- SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.Yahoo Finance·Apr 21, 2026
- PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing CompaniesYahoo Finance·Apr 17, 2026
- NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant BiosciencesYahoo Finance·Apr 13, 2026
- Pacific Sun Packaging to Showcase Solutions at ITAD Europe 2026, Targeting Global Market ExpansionYahoo Finance·Apr 10, 2026
- AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 FirmYahoo Finance·Apr 9, 2026
- Why PMGC Shares Are Rocketing On Wednesday?Benzinga·Apr 8, 2026
- PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition StrategyYahoo Finance·Apr 8, 2026
- Why Are PMGC Shares Tumbling On Tuesday?Benzinga·Apr 7, 2026
- What's Going On With PMGC Stock Monday?Benzinga·Apr 6, 2026
- NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial ApplicationsYahoo Finance·Apr 6, 2026
- PMGC Holdings Inc. Announces the Formation of New Subsidiary, NorthStrive Defense Tech to Target High-Growth Defense, Drone and Autonomous Systems SectorYahoo Finance·Apr 2, 2026
- PMGC Holdings Dips 50% After Massive Rally: What's Going On With ELAB StockBenzinga·Apr 2, 2026
- Wall Street Set to Open Higher as Trump Says US Will Consider Ceasefire if Hormuz Strait OpenedYahoo Finance·Apr 1, 2026
- AGA Precision Systems Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet ProductsYahoo Finance·Mar 31, 2026
- PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024Yahoo Finance·Mar 30, 2026
- NorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 TreatmentsYahoo Finance·Mar 27, 2026
- SVM Machining, Inc. Secures ITAR Registration, Enabling Entry into U.S. Defense Manufacturing ContractsYahoo Finance·Mar 24, 2026
- NorthStrive Biosciences Announces Launch of EL-32 Preclinical Study Evaluating Muscle Preservation in GLP-1 Weight Loss TherapyYahoo Finance·Mar 10, 2026
- PMGC Holdings Inc. Announces Anticipated Reverse Stock SplitYahoo Finance·Mar 4, 2026
- NorthStrive Biosciences Files 10 U.S. Patent Applications for EL-22 and EL-32 Targeting Muscle Growth and Yield Enhancement in Farmed AnimalsYahoo Finance·Feb 19, 2026
All 24 articles loaded
Price Data
Open$2.28
Previous Close$2.20
Day High$2.29
Day Low$2.14
52 Week High—
52 Week Low—
Fundamentals
Market Cap$9M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume479K
Avg Volume (10D)—
Shares Outstanding4.5M
About PMGC Holdings Inc
PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.
MaterialsPHARMACEUTICAL PREPARATIONS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICPHARMACEUTICAL PREPARATIONS
CIK—
Composite FIGI—
Share Class FIGI—